← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Ophidion, Inc.
Pasadena, CA
$2,245,584
Total funding
4
Grants
Funding over time
peak $624K · FY2008–16$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$2,245,584 · 4
By mechanism
R43$1,156,365 · 2
R44$793,191 · 1
R41$296,028 · 1
Investigators at Ophidion, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development of a5 nicotinic receptor agonists for smoking cessation$407,007
R44 · FY2016 · DA
Development of a5 nicotinic receptor agonists for smoking cessation$386,184
R44 · FY2015 · DA
siRNA Mediated Modulation of Lynx1 for Cognitive Enhancement$328,348
R43 · FY2012 · MH
Biologic approach to targeting a nicotinic receptor accessory molecule for cognit$328,017
R43 · FY2011 · MH
In vivo and in vitro tools to target CHRNA5 for smoking cessation.$296,028
R41 · FY2011 · DA
Improved Cell Line and Assay Development of Nicotinic Receptor Complexes for HTS$250,000
R43 · FY2009 · MH
Improved Cell Line and Assay Development of Nicotinic Receptor Complexes for HTS$250,000
R43 · FY2008 · MH